Every GLP-1 provider in 2026 has picked a side: one price at every dose, or a ladder that climbs with your milligrams. Marketing makes both sound like the obvious deal. We ran the math at every dose path — here's who actually wins where.
Key Takeaways
- Flat pricing wins for the typical patient: anyone titrating to mid/high doses and staying 6+ months.
- Tiered pricing wins only for confirmed low-dose responders and low-dose maintenance patients.
- The danger zone in tiered plans is the top-tier cliff — some programs jump sharply at higher doses (a known example: ~$229/mo stepping to $399/mo at 7.5mg+).
- Verdict: if you don't yet know your maintenance dose, take flat. If you know it and it's low, shop tiers.
The Contenders
Flat model: $179–$249/month month-to-month (down to $49–$99 on commitments), identical from starter dose to max. Tiered model: attractive entry pricing at low doses ($99–$149 is common), climbing with each escalation — sometimes gently, sometimes with a documented cliff at the top tiers.
Round 1: The Standard Titrator (the typical patient)
Path: low dose months 1–2, mid months 3–4, high dose months 5–12.
| Model | Months 1–4 | Months 5–12 | Year total |
|---|---|---|---|
| Flat $179/mo | $716 | $1,432 | $2,148 |
| Flat annual-commit $99/mo | $396 | $792 | $1,188 |
| Tiered $129/$179/$259 | $616 | $2,072 | $2,688 |
| Tiered with top-tier cliff ($229→$399) | $916 | $3,192 | $4,108 |
Winner: flat, decisively. The tiered plan's cheap early months are a loss leader for the expensive year that follows — and the cliff variant nearly doubles the flat plan's cost.
Round 2: The Low-Dose Responder
Path: appetite controlled at 0.5–1.0mg all year. Tiered at $99–$149 beats flat's $179 month-to-month rate — though flat annual pricing at $49–$99 claws the verdict back. Winner: tiered on monthly terms, flat on commitment terms — a genuine tie decided by your appetite for commitment.
Round 3: The Maintenance Stepper-Down
Year-two patient dropping to a minimal dose. Same shape as Round 2, with one wrinkle in tiered plans' favor: you already know your dose, so the uncertainty premium flat pricing exists to insure against is worth nothing to you. Winner: whichever quotes the lowest number for your known dose — you can finally shop like it's a commodity.
The Questions That Settle It
- Tiered plans: demand the complete dose-price schedule in writing, top tier included. Cliffs live where the marketing doesn't point.
- Flat plans: what's the commitment, and the medical-exit terms?
- Both: are dose changes and clinical follow-ups included, or billed?
The Flat-Price Field We Track
Telos Rx — Semaglutide
Compounded semaglutide — from $49/mo on 12-month plans
Identical flat-at-every-dose structure on the semaglutide side.
Compounded medications are not FDA-approved.
Visit Telos Rx Paid linkTelos Rx — Tirzepatide
Compounded tirzepatide — from $49/mo on 12-month plans
$199 month-to-month sliding to $49/mo annual, flat at every dose, FSA/HSA accepted, cancel anytime.
Compounded medications are not FDA-approved.
Visit Telos Rx Paid linkEmbody
Injectable semaglutide — $149 first month
Our lead injectable pick: physician-supervised semaglutide with clean flat pricing after the intro month.
Compounded medications are not FDA-approved.
Visit Embody Paid linkFinal verdict: Flat pricing is the correct default for anyone whose maintenance dose is still unknown — which is nearly everyone at signup. Tiered is a specialist tool for people who already know they run cheap.
Affiliate disclosure: Links marked "Paid link" are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This supports our independent research.
Compounded medication notice: Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Brand-name alternatives (Wegovy, Ozempic, Zepbound, Rybelsus) are FDA-approved.
Medical disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs. Always consult a licensed healthcare provider about diagnosis, treatment, dosing, and whether these medications are appropriate for you.